Old Web
English
Sign In
Acemap
>
authorDetail
>
Kayo Kodama Lievre
Kayo Kodama Lievre
Novartis
Lanreotide
Pasireotide
Acromegaly
Octreotide
Medicine
2
Papers
231
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
2014
The Lancet Diabetes & Endocrinology
Mônica R. Gadelha
Marcello D. Bronstein
Thierry Brue
Mihail Coculescu
Maria Fleseriu
Mirtha Guitelman
Vyacheslav Pronin
G. Raverot
Ilan Shimon
Kayo Kodama Lievre
Juergen Fleck
Mounir Aout
Alberto M Pedroncelli
Annamaria Colao
Show All
Source
Cite
Save
Citations (228)
Pasireotide LAR demonstrates superior efficacy versus octreotide LAR and lanreotide ATG in patients with inadequately controlled acromegaly: results from a phase III, multicentre, randomized study (PAOLA)
2014
Growth Hormone & Igf Research
Monica R Gadelha
Marcello Bronstein
Thierry Brue
Mihail Coculescu
Maria Fleseriu
Mirtha Guitelman
Vyacheslav Pronin
G. Raverot
Ilan Shimon
Kayo Kodama Lievre
Juergen Fleck
Mounir Aout
Alberto M Pedroncelli
Annamaria Colao
Show All
Source
Cite
Save
Citations (3)
1